Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Innovision IPO Day 2: Issue sees tepid demand as GMP remains weak. Should you apply or not?
Innovision IPO GMP today is nil. This means that shares of Innovision are trading at par with the IPO price. At the prevailing GMP, Innovision IPO listing price will be the same as the offer price. Shares of Innovision IPO are slated to list on both BSE and NSE on March 17.
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Gaudium IVF IPO allotment: Steps to check status, listing date and other key details
Shares of Gaudium IVF and Women Health Ltd are tentatively scheduled to be listed on the NSE and BSE on Friday, February 27.
2026 may reward stock pickers; autos, financials at fair valuations: Kenneth Andrade
Kenneth Andrade, Founder & CIO of Old Bridge Asset Management advises focusing on companies where major capital expenditure is complete, particularly in sectors like chemicals, pharmaceuticals, and select commodities. Andrade remains cautious on IT services but sees significant value in businesses with strong balance sheets and attractive valuations, even amidst bearish macroeconomic headwinds, citing IEX as a key example.
LIVE: Nifty fails to hold 24,000; metals outperform | Closing Bell
Markets ended lower, snapping a two-day winning streak, with benchmark indices pressured by weakness in financials and select heavyweight stocks. The Sensex declined over 300 points, while the Nifty failed to hold above the crucial 24,000 mark. Market breadth remained weak, with decliners outnumbering advancers by nearly two-to-one on the BSE, reflecting broad-based selling. Investor caution was also evident as the India VIX climbed around 5%, indicating a pickup in volatility expectations. On the sectoral front, pharma and metal stocks bucked the trend, with the Metal index snapping a three-session losing streak. Banking stocks remained under pressure, dragging the Bank Nifty below the 58,000 mark. Among the Nifty 50 gainers, Dr Reddy's, Max Healthcare and Trent led the advances, while Kotak Mahindra Bank, Mahindra & Mahindra and IndiGo were among the biggest losers of the session.
Taking Stock: Sensex, Nifty end flat ahead of RBI policy; consumer durables, capital goods shine
More than 120 stocks touched their 52-week high on the BSE, including Cemindia Projects, Nippon Life India Asset Management, Jindal Saw, HFCL, Syrma SGS, Laurus Labs, Polycab, Vodafone Idea, Federal Bank, IFCI, JK Bank, Welspun Corp, RBL Bank, among others.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.